Cargando…
Development and Validation of a Nomogram to Predict Cancer-Specific Survival for Middle-Aged Patients With Early-Stage Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma is a common cause of death in middle-aged patients. We aimed to construct a new nomogram to predict cancer-specific survival (CSS) in middle-aged patients with hepatocellular carcinoma at an early stage. METHOD: We collected clinicopathological information on ear...
Autores principales: | Wen, Chong, Tang, Jie, Luo, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918547/ https://www.ncbi.nlm.nih.gov/pubmed/35296046 http://dx.doi.org/10.3389/fpubh.2022.848716 |
Ejemplares similares
-
Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study
por: Yin, Fangxu, et al.
Publicado: (2022) -
A Nomogram for Predicting Cancer-Specific Survival in Children With Wilms Tumor: A Study Based on SEER Database and External Validation in China
por: Tan, Xiaojun, et al.
Publicado: (2022) -
Development and Validation of a Nomogram to Predict Cancer-Specific Survival in Elderly Patients With Papillary Renal Cell Carcinoma
por: Zhanghuang, Chenghao, et al.
Publicado: (2022) -
Develop and validate nomogram to predict cancer-specific survival for patients with testicular yolk sac tumors
por: Li, Maoxian, et al.
Publicado: (2022) -
Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy
por: Song, Jiazhao, et al.
Publicado: (2023)